Ivermectin is an anti-inflammatory and antiparasitic medicine belonging to the group of avermectives. First of all, it has an anti-inflammatory effect, which is achieved by suppressing the production of inflammatory cytokines, which are induced by lipopolysaccharides. The primary field of application of Ivermectin is anti-inflammatory therapy of inflammatory skin processes in animals, as well as in humans. A kind of side effect of ivermectin is its ability to cause the death of parasites. It is due to selective binding and high affinity for glutamate-gated chloride channels. These channels are located in the nerve muscle cells of invertebrate parasites. It is noted that there is still no consensus in the scientific community about why Ivermectin is effective against certain types of skin inflammation. In addition to its direct anti-inflammatory effect, this may be due to its ability to kill Demodex mites, which cause severe inflammatory skin reactions in some people.
In addition to these properties of Ivermectin, the coronavirus pandemic revealed such an amazing ability of this drug as its ability to prevent the severe course of a new coronavirus infection and be a prophylaxis against this disease. The so-called miracle of Ivermectin has been documented in Japan, where there is a high population density and a high risk of transmission of infectious diseases. In many countries, neither masks, nor vaccinations, nor restrictions on the gathering of large numbers of people have brought tangible results. Meanwhile, Japan at the end of 2020 was among the countries where the rate of new infections and new deaths dropped sharply. This phenomenon has even been called the Japanese anomaly. In terms of the number of cases, much less populated Italy surpassed Japan by 17 times, in terms of the number of deaths, almost 4 times. At the same time, in the summer of 2020, the Japanese experienced very high rates of both morbidity and mortality. However, by autumn, a certain fact intervened in the matter, which made it possible to significantly reduce morbidity and mortality.
This factor was the use of Ivermectin. On October 29, 2020 in Natural News a publication was placed, the title of which was as follows: "Japan ends vaccine-induced pandemic by legalizing IVERMECTIN, while pharma-controlled media pretends masks and vaccines were the savior" [1]. Of course, such a title is quite pretentious and not very scientific, but the fact remains: at the end of August, Japanese doctors began to massively treat people with Ivermectin. In the treatment of humans, Ivermectin is commonly used for diseases such as head lice and scabies, river blindness, trongyloidosis, trichuriasis, ascariasis, and lymphatic filariasis. However, empirically, it was found that the drug is very effective in the treatment of those infected with COVID and even as a means of preventing this infection. Doctors acted almost blindly, by trial and error.
Many medicines available in the arsenal of modern medicine help in the treatment and prevention of coronavirus. Stromectol is just one of them, you can buy generic Ivermectin online. However, medical pharmacological regulators are firmly guarding vaccine manufacturers who do not need competitors. Neither Hydroxychloroquine, nor Ivermectin, nor other drugs can get the approval of the American medical regulator FDA and even organize official clinical trials. [2]
Ivermectin is able to inhibit the enzyme that is responsible for duplicating the viral genome in infected cells. Laboratory experiments on infected cells have shown that this drug prevents the coronavirus from ferrying its genetic material into the nucleus of the host cell. All this prevents the coronavirus from creating new viral particles.
The average daily dosage of Ivermectin in the treatment and prevention of Covid is about 12 mg. The exact calculation of the amount of the substance is desirably determined based on the weight of the patient. It is undesirable to use the medicine in persons under 18 years of age. In contrast to antiparasitic therapy, in the prevention and treatment of COVID-19, the duration of use is continuous for at least two weeks.
In the first quarter of 2023, Ivermectin is used in parts of Bangladesh, Argentina, Mexico, Japan. Partial clinical trials of Ivermectin as a treatment for COVID-19 were carried out in the UK, but for some reason they were not brought to the final. In the United States, the FLCCC (Front Line COVID-19 Critical Care Alliance) was created in 2020, which has collected a large amount of information on the use of Ivermectin for the treatment of those infected with coronavirus in South America and Asia. The collected material reflects a very encouraging experience. Although there is no complete clinical picture for the drug (there is no complete clinical picture for vaccines today), but, the evaluation of Ivermectin continues in 31 current (ongoing) studies.
Medically reviewed by: Dr. Stamatios Lerakis